| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/04/2008 | WO2008106478A1 Compositions and methods for modification of target cells and to their uses thereof |
| 09/04/2008 | WO2008106469A1 Living cell force sensors and methods of using same |
| 09/04/2008 | WO2008105931A2 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| 09/04/2008 | WO2008105919A2 Nanomechanical characterization of cellular activity |
| 09/04/2008 | WO2008105886A2 HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 09/04/2008 | WO2008105499A1 Method for production of tooth, and tooth produced by the method |
| 09/04/2008 | WO2008105454A1 Cell capable of expressing lacritin at high level |
| 09/04/2008 | WO2008105392A1 3-amino-2-indolylbutyrolactam derivative, process for production of the same, and pharmaceutical agent comprising the same as active ingredient |
| 09/04/2008 | WO2008104065A1 Neural cell preparations and methods of making and using them |
| 09/04/2008 | WO2008104064A1 Compositions and methods for treating peripheral vascular diseases |
| 09/04/2008 | WO2008104063A1 Method of reducing curvature in a meniscus of liquid medium |
| 09/04/2008 | WO2008104062A2 Selective release of pro-apoptotic bcl-2 family members and their contribution to the bystander effect |
| 09/04/2008 | WO2008104042A1 Semen manipulation process |
| 09/04/2008 | WO2008088863A3 Stem cell gene targeting |
| 09/04/2008 | WO2008081478A3 A chimeric promoter and a method thereof |
| 09/04/2008 | WO2008073166A3 Multi-variant cell indication technique |
| 09/04/2008 | WO2008068589A3 Neural stem cell medium and differentiation method |
| 09/04/2008 | WO2007139926A3 Crac channel and modulator screening methods |
| 09/04/2008 | WO2007130060A3 Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues |
| 09/04/2008 | WO2006047535A3 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 09/04/2008 | US20080216201 Gene Expression Modulating Element |
| 09/04/2008 | US20080216200 Alternative splicing factors polynucleotides, polypeptides and uses thereof |
| 09/04/2008 | US20080216197 Pyridoxine biosynthetic protein for use in identifying agents which suppess growth of plants |
| 09/04/2008 | US20080216195 Drought and high light tolerant transgenic plants |
| 09/04/2008 | US20080216193 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 09/04/2008 | US20080216192 Potato Cultivar FL 2086 |
| 09/04/2008 | US20080216186 Potato Cultivar FL 2085 |
| 09/04/2008 | US20080216184 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 09/04/2008 | US20080216181 Novel Alcohol Dehydrogenases |
| 09/04/2008 | US20080215073 Tissue construct-forming substrate, tissue construct-forming kit, method for forming tissue construct using the same and three-dimensional tissue construct formed by the method |
| 09/04/2008 | US20080214801 Condensation of a specifically engineered phosphine containing a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine by-product and producing an amide bond in final product |
| 09/04/2008 | US20080214799 Fetal gene expression network/profile for identifying gene products which confer apoptosis resistant and interleukin-6 repressive phenotypes; treating and/or preventing ischemic reperfusion injuries |
| 09/04/2008 | US20080214790 Leafthopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/04/2008 | US20080214788 Interferon-like protein zcyto21 |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214784 Human t1r2 taste receptor polypeptides |
| 09/04/2008 | US20080214668 Use of retinoids to treat high blood pressure and other cardiovascular disease |
| 09/04/2008 | US20080214667 Nucleic acid molecule; complementary to a nucleotide sequence encoding a polypeptide having elongase activity |
| 09/04/2008 | US20080214665 Novel Approach to Anti-Microbial Host Defense with Molecular Shields with Lipoxin Compounds |
| 09/04/2008 | US20080214563 Benzimidazole Thiophene Compounds As Plk Modulators |
| 09/04/2008 | US20080214541 Such as 2-(1-naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; differentiating cells into osteoblast lineage; osteoporosis |
| 09/04/2008 | US20080214482 Retromer-based assays and methods for treating alzheimer's disease |
| 09/04/2008 | US20080214468 Administering a peptide, identified through a phage display library; osteogenesis, cell adhesion/angiogenesis, inhibiting cancer cell metastasis |
| 09/04/2008 | US20080214464 Method for the Production of Biologically Active Rhngf |
| 09/04/2008 | US20080214463 Method for cell adhesion and wound healing |
| 09/04/2008 | US20080214462 FIX-Mutant Proteins for Hemophilia B Treatment |
| 09/04/2008 | US20080214461 FVIII-Independent FIX-Mutant Proteins for Hemophilia A Treatment |
| 09/04/2008 | US20080214450 Nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides |
| 09/04/2008 | US20080214440 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
| 09/04/2008 | US20080214411 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/04/2008 | US20080214403 Parallel Methods For Insertional Mutagenesis |
| 09/04/2008 | US20080213897 culturing conifer somatic embryos on sterile germination medium for a time to produce germinants comprising visible, well-defined epicotyl and radical; placing germinants still on germination medium into a cold environment of 0.5 degrees C. to 10 degrees C. for a time period up to six months |
| 09/04/2008 | US20080213896 culturing conifer somatic embryos on sterile germination medium for a time to produce germinants comprising visible, well-defined epicotyl and radical; placing germinants still on germination medium into a cold environment of 0.5 degrees C. to 10 degrees C. for a time period up to six months |
| 09/04/2008 | US20080213895 Method for culturing dendritic cells (DC) and cytokine-induced killer cells (D-CIK) and applications thereof |
| 09/04/2008 | US20080213894 Discardable bioreactor for use in propagation of preferential cells |
| 09/04/2008 | US20080213893 Isolation of neural stem cells using gangliosides and other surface markers |
| 09/04/2008 | US20080213892 Propagating nervous system tissue in nutrient broth comprising wnt polypeptides; tissue engineering; regenerative medicine |
| 09/04/2008 | US20080213891 RNAi Agents Comprising Universal Nucleobases |
| 09/04/2008 | US20080213890 Antibody-avidin fusion proteins as cytotoxic drugs |
| 09/04/2008 | US20080213889 Increasing oocyte maturation via treating oocyte in vitro with gonadotropin hormone and hydrolase inhibitor; treating fertility disorders |
| 09/04/2008 | US20080213888 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 09/04/2008 | US20080213887 Methods and compositions for cryopreserving oocytes |
| 09/04/2008 | US20080213886 Albumin fusion proteins |
| 09/04/2008 | US20080213885 Composition and method for enabling proliferation of pluripotent stem cells |
| 09/04/2008 | US20080213884 Transgenic cell expressing vector comprising tissue specific regulatory sequences; tissue target gene expression |
| 09/04/2008 | US20080213883 Silica nanoparticles in basic amino acid-silica sols |
| 09/04/2008 | US20080213882 Method for Isolating Dermal Papilla Cells and Uses Thereof |
| 09/04/2008 | US20080213881 Expression vector coding nucleotide sequences comprising novel cytokine upregulated by interleukin-9 for use in treatment and prevention of cell hodgkin's disease |
| 09/04/2008 | US20080213880 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 09/04/2008 | US20080213879 Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
| 09/04/2008 | US20080213871 Expression vector comprising nucleotide sequences coding short interfering RNA for use in increasing cellulose production in plants and drecreasing cost of pretreating biofuels |
| 09/04/2008 | US20080213869 Using sol-gel chemotaxis induced concentration gradient to separate cells/organisms within suspension |
| 09/04/2008 | US20080213861 Using targeted gene expression inhibition to treat and prevent viral infection |
| 09/04/2008 | US20080213857 Coating liquid comprising cell adhesion inhibiting properties and which is decomposed or denatured by action of photocatalyst for use in forming cell culture supports |
| 09/04/2008 | US20080213851 Enzymatic Method for Producing Bioactive, OsteoblastStimulating Surfaces and Use Thereof |
| 09/04/2008 | US20080213839 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 09/04/2008 | US20080213838 Expression vector comprising nucleotide sequences coding aminopeptidase A (APA) protein for use in prvention and treatment of preclampsia |
| 09/04/2008 | US20080213837 Apo-3 ligand polypeptide |
| 09/04/2008 | US20080213836 Modified enteropeptidase protein |
| 09/04/2008 | US20080213834 Gsk3 ligands and polynucleotides encoding gsk3 ligands |
| 09/04/2008 | US20080213832 Sesquiterpene synthases and methods of use |
| 09/04/2008 | US20080213831 Human cytokine receptor |
| 09/04/2008 | US20080213825 Apparatus which utilizes cold system to organize and treat disorganized tumor cells |
| 09/04/2008 | US20080213817 Enhancement of Th2-Dependent and Inflammatory Response |
| 09/04/2008 | US20080213812 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213779 Using variation in NLR family, pyrin domain containing 7 (NALP7) gene as evaluative tool in diagnosis/prognosis of gestation disorders |
| 09/04/2008 | US20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/04/2008 | US20080213751 Ilcs based pattern recognition of sepsis |
| 09/04/2008 | US20080213750 HCV Variants and Related Methods |
| 09/04/2008 | US20080213743 Modifying settling velocity of fluid component by addition of anticoagulant agents |
| 09/04/2008 | US20080213742 High surface cultivation system |
| 09/04/2008 | US20080213389 Three-Dimensional Scaffolds for Tissue Engineering Made by Processing Complex Extracts of Natural Extracellular Matrices |
| 09/04/2008 | US20080213387 Isolated cytotrophoblast stem cell expresses HLA-G and HLA class I antigen; cytokeratin 7; stage specific embryonic antigen 1; human placental lactogen; caudal related homeobox; vimentin; Cd9 marker; chimeric cell for the modulation of cell/tissue rejection in transplantation therapy |
| 09/04/2008 | US20080213340 Alzheimer's prevention oral vaccines; inserting expression vector into agrobacterium and culturing |
| 09/04/2008 | US20080213332 Harvesting stem cells; producing medical implants capable of in vivo generation of cell populations and/or tissues |
| 09/04/2008 | US20080213303 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/04/2008 | US20080213295 Estrogen receptor polypeptide which induces immune respone; for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 09/04/2008 | US20080213290 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |